Maiden Group

Maiden Pharmaceuticals is an Indian pharmaceutical company headquartered in New Delhi that specializes in the manufacture and export of generic medicines. Established in 1990, the company produces a wide range of dosage forms, including tablets, capsules, liquid orals, and injectables, across various therapeutic categories such as pediatrics and gastroenterology. The firm operates manufacturing facilities in Haryana and primarily targets emerging markets in Asia, Africa, and Latin America. In 2022, the company gained international attention following a World Health Organization (WHO) medical product alert regarding contaminated cough syrups. Despite regulatory challenges, the company remains a significant entity in the Indian generic export sector.